Wissenschaft

Dr. med. Michael Amann

Wissenschaftliche Schwerpunkte: Troponin-Algorithmen beim Herzinfarkt, kardiale Biomarker und Thrombozytenfunktion.

18 Veröffentlichungen 2012 – 2022

Veröffentlichungen

  1. 2022Performance of the European Society of Cardiology 0/1-hour, 0/2-hour, and 0/3-hour algorithms for rapid triage of acute myocardial infarction: An international collaborative meta-analysis.Chiang CH, Chiang CH, Pickering JW, Stoyanov KM, Chew DP, Neumann JT, Ojeda F, Sörensen NA, Su KY, Kavsak P, Worster A, Inoue K, Johannessen TR, Atar D, Amann M, Hochholzer W, Mokhtari A, Ekelund U, Twerenbold R, Mueller C, Bahrmann P, Buttinger N, Dooley M, Ruangsomboon O, Nowak RM, DeFilippi CR, Peacock WF, Neilan TG, Liu MA, Hsu WT, Lee GH, Tang PU, Ma KSK, Westermann D, Blankenberg S, Giannitsis E, Than MP, Lee CCAnn Intern Med. 2022 Jan; 175(1): 101-113
  2. 2021Prevalence and causes of myocardial infarction with non-obstructive coronary arteries in a contemporary cohort of patients with suspected myocardial infarction.Dees D, Rahimi F, Amann M, Nührenberg TG, Löffelhardt N, Schmitz R, Valina CM, Neumann FJ, Hochholzer WJ Clin Med. 2021 Nov 6; 10(21): 5188
  3. 2019Evaluation of a 1-hour troponin algorithm for diagnosing myocardial infarction in high-risk patients admitted to a chest pain unit: the prospective FAST-MI cohort study.Amann M, Gaiser F, Schwenk SI, Rahimi F, Schmitz R, Mashayekhi K, Ferenc M, Neumann FJ, Valina CM, Hochholzer WBMJ Open. 2019 Nov 7; 9(11)
  4. 2018Risk of discontinuation of clopidogrel after 1 month following bare-metal stents: a propensity-score adjusted comparison with continued administration of clopidogrel after drug-eluting stents.Valina CM, Merz S, Löffelhardt N, Amann M, Ferenc M, Stratz C, Neumann FJ, Hochholzer WJ Thromb Thrombolysis. 2018 Apr; 45(3): 432-439
  5. 2017On-clopidogrel platelet reactivity as predictor for long-term clinical outcome in patients after planned discontinuation of clopidogrel.Bömicke T, Valina CM, Stratz C, Amann M, Neumann FJ, Hochholzer WThromb Haemost. 2017 Jul 26; 117(8): 1644-1650
  6. 2017Randomized Comparison of Oral P2Y12-Receptor Inhibitor Loading Strategies for Transitioning From Cangrelor: The ExcelsiorLOAD2 Trial.Hochholzer W, Kleiner P, Younas I, Valina CM, Löffelhardt N, Amann M, Bömicke T, Ferenc M, Hauschke D, Trenk D, Neumann FJ, Stratz CJACC Cardiovasc Interv. 2017 Jan 23; 10(2): 121-129
  7. 2016Impact of reticulated platelets on antiplatelet response to thienopyridines is independent of platelet turnover.Stratz C, Nührenberg T, Amann M, Cederqvist M, Kleiner P, Valina CM, Trenk D, Neumann FJ, Hochholzer WThromb Haemost. 2016 Oct 28; 116(5): 941-948
  8. 2016Comparison of Immature Platelet Count to Established Predictors of Platelet Reactivity During Thienopyridine Therapy.Stratz C, Bömicke T, Younas I, Kittel A, Amann M, Valina CM, Nührenberg T, Trenk D, Neumann FJ, Hochholzer WJ Am Coll Cardiol. 2016 Jul 19; 68(3): 286-293
  9. 2016Predictors of high-sensitivity cardiac troponin in stable patients undergoing coronary angiography.Valina CM, Amann M, Stratz C, Trenk D, Löffelhardt N, Ferenc M, Neumann FJ, Hochholzer WEuroIntervention. 2016 Jun 20; 12(3): 329-36
  10. 2016Validation of a P2Y12-receptor specific whole blood platelet aggregation assay.Amann M, Ferenc M, Valina CM, Bömicke T, Stratz C, Leggewie S, Trenk D, Neumann FJ, Hochholzer WPlatelets. 2016 Nov; 27(7): 668-672
  11. 2016Randomized Comparison of Different Thienopyridine Loading Strategies in Patients Undergoing Elective Coronary Intervention: The ExcelsiorLOAD Trial.Hochholzer W, Amann M, Titov A, Younas I, Löffelhardt N, Riede F, Potocnik C, Stratz C, Hauschke D, Trenk D, Neumann FJ, Valina CMJACC Cardiovasc Interv. 2016 Feb 8; 9(3): 219-227
  12. 2015Large platelets but not putative endothelial progenitor cells are associated with low strut coverage after drug-eluting stent implantation.Nührenberg TG, Zhao M, Stratz C, Amann M, Valina CM, Gick M, Trenk D, Binder H, Büttner HJ, Neumann FJInt J Cardiol. 2015 Nov 15; 199: 358-65
  13. 2015Intrinsic platelet reactivity before start with clopidogrel as predictor for on-clopidogrel platelet function and long-term clinical outcome.Hochholzer W, Valina CM, Bömicke T, Amann M, Stratz C, Nührenberg T, Trenk D, Neumann FJThromb Haemost. 2015 Jul; 114(1): 109-14
  14. 2014High-sensitivity cardiac troponin for risk prediction in patients with and without coronary heart disease.Hochholzer W, Valina CM, Stratz C, Amann M, Schlittenhardt D, Büttner HJ, Trenk D, Neumann FJInt J Cardiol. 2014 Sep 20; 176(2): 444-9
  15. 2014Controlled type II diabetes mellitus has no major influence on platelet micro-RNA expression. Results from micro-array profiling in a cohort of 60 patients.Stratz C, Nührenberg T, Fiebich BL, Amann M, Kumar A, Binder H, Hoffmann I, Valina C, Hochholzer W, Trenk D, Neumann FJThromb Haemost. 2014 May 5; 111(5): 902-11
  16. 2013Clopidogrel pretreatment of patients with ST-elevation myocardial infarction does not affect platelet reactivity after subsequent prasugrel-loading: platelet reactivity in an observational study.Nührenberg TG, Trenk D, Leggewie S, Ristau I, Amann M, Stratz C, Hochholzer W, Valina CM, Neumann FJPlatelets. 2013; 24(7): 549-53
  17. 2012Transanal endoscopic microsurgery in treatment of rectal adenomas and T1 low-risk carcinomas.Amann M, Modabber A, Burghardt J, Stratz C, Falch C, Buess GF, Kirschniak AWorld J Surg Oncol. 2012 Nov 26; 10: 255
  18. 2012Novel biomarkers in cardiovascular disease: research tools or ready for personalized medicine?Stratz C, Amann M, Berg DD, Morrow DA, Neumann FJ, Hochholzer WCardiol Rev. 2012 May-Jun; 20(3): 111-7

← Zurück zu Dr. med. Michael Amann